Enhanced inflammasome activation and IL-1β secretion by monocytes from CRMO patients is reversible by co-culture with recombinant IL-10 or IL-19 [41••], suggesting an immunomodulatory function of IL-10 and IL-19 on inflammasome activation. The gene discussed is IL1B; the disease is chronic recurrent multifocal osteomyelitis.